A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
A Case of Sorafenib-induced DRESS Syndrome in Hepatocelluar Carcinoma
2016
Korean Journal of Gastroenterology
Sorafenib is currently the only targeted therapy available for advanced stage hepatocellular carcinoma (HCC). Cutaneous adverse events associated with sorafenib treatment include hand-foot skin reaction, but there has been no report of drug reaction (or rash) with eosinophilia and systemic symptoms (DRESS) syndrome. Here, we report a case of 72-year-old man with HCC and alcoholic liver cirrhosis who developed skin eruptions, fever, eosinophilia, and deteriorated hepatic and renal function under
doi:10.4166/kjg.2016.67.6.337
pmid:27312836
fatcat:fw5gsaumuzcy7bsu2rxty6623y